Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma
Authors
Keywords
-
Journal
CELLULAR & MOLECULAR BIOLOGY LETTERS
Volume 27, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-29
DOI
10.1186/s11658-022-00403-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
- (2021) Laetitia Douguet et al. Nature Communications
- Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade
- (2021) Shengqing Stan Gu et al. Cancer Discovery
- Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer
- (2021) Cecilia R. Chambers et al. Molecular Oncology
- METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway
- (2021) Hao Wu et al. Annals of Translational Medicine
- A non-proliferative role of pyrimidine metabolism in cancer
- (2020) Aarif Siddiqui et al. Molecular Metabolism
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
- (2020) Xiaorong Gu et al. LEUKEMIA
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
- (2020) Shaima'a Hamarsheh et al. Frontiers in Immunology
- A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27
- (2020) Dehai Wu et al. ONCOGENE
- Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma
- (2020) Jie Cai et al. Oncogenesis
- TISIDB: an integrated repository portal for tumor-immune system interactions
- (2019) Beibei Ru et al. BIOINFORMATICS
- Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
- (2019) Elodie Villa et al. Cancers
- Uridine‐cytidine kinase 2 ( UCK 2): A potential diagnostic and prognostic biomarker for lung cancer
- (2019) Yingjie Wu et al. CANCER SCIENCE
- Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
- (2019) Xiaofan Lu et al. NEOPLASIA
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
- (2019) Qiang Gao et al. CELL
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells
- (2018) Martina Bajzikova et al. Cell Metabolism
- UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma
- (2018) Shuo Yu et al. IUBMB LIFE
- Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness
- (2018) Shanzhou Huang et al. MOLECULAR CARCINOGENESIS
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway
- (2018) Qiming Zhou et al. Cancer Management and Research
- Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis
- (2017) Guosong Shen et al. Journal of Breast Cancer
- The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma
- (2016) André B.P. van Kuilenburg et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Transcriptional Induction of Periostin by a Sulfatase 2–TGFβ1–SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma
- (2016) Gang Chen et al. CANCER RESEARCH
- Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines
- (2016) R. Meinsma et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Migratory CD103+dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12
- (2015) Bart Everts et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started